Target intelligence / Profile preview

Ornithine ketoglutarate (OKG)

Target
OKG
Molecular classification
Amino acid salt, Metabolic intermediate
01

Overview

Ornithine ketoglutarate (OKG) is a salt composed of two molecules of L-ornithine and one molecule of alpha-ketoglutarate. It is primarily utilized as a nutritional supplement and therapeutic agent in catabolic states, such as severe burns, trauma, and malnutrition, to promote protein synthesis and wound healing. OKG functions by serving as a metabolic precursor to critical amino acids like glutamine and arginine, which are often depleted during physiological stress. Additionally, it exerts anabolic effects by stimulating the release of hormones such as insulin and growth hormone, which help maintain muscle mass and improve nitrogen balance. While it is a bioactive molecule with significant clinical applications, it is classified as a metabolic substrate or drug rather than a traditional therapeutic target like a receptor or enzyme.

Other names
L-Ornithine 2-oxoglutarateOrnithine alpha-ketoglutarateCétornan
02

Mechanism of action

Ornithine ketoglutarate acts as a precursor for the synthesis of glutamine, arginine, and proline, which are essential for protein metabolism and tissue repair. It also stimulates the secretion of anabolic hormones such as insulin and growth hormone, thereby promoting a positive nitrogen balance and reducing muscle protein breakdown (proteolysis).

03

Biological functions

Protein synthesis stimulationAmmonia detoxificationPrecursor for glutamine and arginine synthesisNitrogen balance regulationWound healing promotion
04

Disease associations

SarcopeniaSevere burnsMalnutritionTrauma recoveryChronic wounds
05

Safety considerations

Gastrointestinal distress (diarrhea, nausea) at high dosesPotential for hyperammonemia in patients with specific urea cycle disordersLimited efficacy data in non-catabolic states
06

Biomarkers

Plasma glutamine levelsUrinary nitrogen excretionPlasma insulin-like growth factor 1 (IGF-1)

Beyond the preview

Go deeper on Ornithine ketoglutarate (OKG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ornithine ketoglutarate (OKG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call